Table 3.
Univariate analysis for disease-free survival (DFS) and overall survival (OS)
| Variable | DFS | OS | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | |
| Age, years | ||||||
| < 65 | — | — | ||||
| ≥ 65 | 0.962 | 0.605–1.530 | 0.870 | 1.071 | 0.648–1.772 | 0.788 |
| Gender | ||||||
| Male | — | — | ||||
| Female | 0.872 | 0.543–1.399 | 0.570 | 1.140 | 0.685–1.897 | 0.614 |
| Location | ||||||
| Ascending | — | — | ||||
| Transverse | 1.297 | 0.622–2.705 | 0.487 | 1.438 | 0.655–3.158 | 0.365 |
| Descending | 1.978 | 0.786–4.979 | 0.148 | 2.340 | 0.909–6.022 | 0.078 |
| Sigmoid | 1.301 | 0.570–2.973 | 0.532 | 0.730 | 0.244–2.186 | 0.574 |
| Rectum | 1.112 | 0.627–1.973 | 0.717 | 1.284 | 0.695–2.372 | 0.424 |
| T stage | ||||||
| T1+T2 | — | — | ||||
| T3+T4 | 2.057 | 1.251–3.381 | 0.004a | 2.200 | 1.281–3.777 | 0.004a |
| N stage | ||||||
| N0 | — | — | ||||
| N1 | 2.154 | 1.353–3.429 | 0.001a | 2.474 | 1.497–4.087 | < 0.001a |
| M stage | ||||||
| M0 | — | — | ||||
| M1 | 3.262 | 1.891–5.629 | < 0.001a | 4.000 | 2.281–7.014 | < 0.001a |
| AJCC stage | ||||||
| I + II | — | — | ||||
| III + IV | 2.451 | 1.519–3.956 | < 0.001a | 2.580 | 1.536–4.334 | < 0.001a |
| Differentiation | ||||||
| Well | — | — | ||||
| Moderate | 2.278 | 1.238–4.192 | 0.008a | 2.486 | 1.274–4.852 | 0.008a |
| Poor | 3.560 | 1.865–6.797 | < 0.001a | 3.700 | 1.833–7.468 | < 0.001a |
| Vessel invasion | ||||||
| No | — | — | ||||
| Yes | 2.067 | 1.197–3.568 | 0.009a | 2.166 | 1.208–3.884 | 0.010a |
| KRT80 expression | ||||||
| Negative | — | — | ||||
| Positive | 3.897 | 2.213–6.864 | < 0.001a | 3.397 | 1.882–6.132 | < 0.001a |
HR hazard ratio, CI confidence interval
aP < 0.05 was considered significant